in the examination methodology so as to mini mize interobserver variation. This part o'f the HANES examination included a complete clini cal examination of the skin and surrounding tissue that considered normal variations in texture and color, certain manifestations of aging, and all pathological changes. Significant diagnoses were documented by tissue biopsy to determine malignancy or culture to identify fungi whenever possible. Estimates were made of actinic ex posure experienced, as welI as actinic damage sustained, and of occupational risk from irritant and allergic contractants.
For an examinee with a sigriificant hand, foot, or generalized problem, the dermatologist made a judgment about the burden to the examinee in terms of discomfort or disability, about care sought, and about the effect expected from current best care possible.
The examinations of persons in this HANES sample were made at 65 preselected locations throughout the country. Of the 28,043 sample persons selected to represent the 194 million persons 1-74 years of age in the U.S. population, there were 20,749, or 74.0 percent, examined. This corresponds to an effective response rate of 75.2 percent after adjustment is made for the effect of oversampling among the poor, preschool children, women of childbearing age (20-44 years), and the elderly. This summary is limited to national esti mates by age and sex of the prevalence of skin disorders and the principal types of skin disease. Skin pathology is more prevalent among males than among fema.Ies (34 percent compared with 29 percent), and the proportion with the major types of skin conditions is generally greater arnon~ males than among females (fi,gure 3). Of the most frequently occurring skin concli tions, males are substantiality more likely than females to have a fungal condition or folliculitis, the prevalence being about three times as great in males. Series 11. Health Resources Administration, DHEW, Rockville, Md. To be published. Diseases of sebaceous glands-
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